HNGE as reported
Hinge Health, Inc. reported $720M of revenue over the trailing twelve months, +50% on the year before. 9 reported series are charted on this page, each one as filed.
$720M
Revenue, trailing twelve months · to Q2 2026 · +50% against the twelve months before
- Net Income
- $109M
Net Income · −121% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $290M
Free Cash Flow · +218% year on year · trailing twelve months to Q2 2026
- Op Margin
- 12%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $720M | +50% | Q2 2026 |
| Net Income | $109M | −121% | Q2 2026 |
| EPS | $3.02 | −131% | Q2 2026 |
| Gross Margin | 84% | n/a | Q2 2026 |
| Op Margin | 12% | n/a | Q2 2026 |
| Net Margin | 14% | n/a | Q2 2026 |
| ROE | −244% | n/a | Q2 2026 |
| ROA | −49% | n/a | Q2 2026 |
| Free Cash Flow | $290M | +218% | Q2 2026 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Hinge Health, Inc. (HNGE) - Revenue & ProfitRevenue & ProfitHinge Health, Inc. (HNGE)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Health Information Services
Ranks #1 of 14 by Smart Score